Targeting DNA repair in ovarian cancer therapy

被引：0
|
作者：
D'Andrea, Alan D. [1 ]
机构：
[1] Dana Farber Canc Inst, Dept Radiat Oncol, Ctr DNA Damage & Repair, Boston, MA 02115 USA
来源：
CLINICAL CANCER RESEARCH | 2016年 / 22卷
关键词：
D O I：
10.1158/1557-3265.OVCA15-IA04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA04
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Targeting mRNA methyltransferase in RNA-dependent DNA repair in cancer therapy
    Lan, Li
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (11)
  • [32] Targeting DNA damage and repair: Embracing the pharmacological era for successful cancer therapy
    Aziz, K.
    Nowsheen, S.
    Pantelias, G.
    Iliakis, G.
    Gorgoulis, V. G.
    Georgakilas, A. G.
    PHARMACOLOGY & THERAPEUTICS, 2012, 133 (03) : 334 - 350
  • [33] Targeting DNA repair defects in prostate cancer
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2020, 17 (08) : 432 - 432
  • [34] Targeting DNA repair defects in prostate cancer
    Clemens Thoma
    Nature Reviews Urology, 2020, 17 : 432 - 432
  • [35] Targeting defective DNA repair in prostate cancer
    Carmichael, Juliet
    Maza, Maria de los Dolores Fenor de la
    Rescigno, Pasquale
    Chandran, Khobe
    de Bono, Johann
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (05) : 503 - 509
  • [36] Epigenetic targeting of DNA repair in lung cancer
    Lok, Benjamin H.
    Rudin, Charles M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (45) : 22429 - 22431
  • [37] Targeting DNA repair proteins for cancer treatment
    Gianluca Tell
    David M. Wilson
    Cellular and Molecular Life Sciences, 2010, 67 : 3569 - 3572
  • [38] Targeting DNA Repair: Beyond Cancer.
    Helleday, T.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2019, 60 : 44 - 45
  • [39] Targeting DNA repair proteins for cancer treatment
    Tell, Gianluca
    Wilson, David M., III
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (21) : 3569 - 3572
  • [40] Targeting Six Hallmarks of Cancer in Ovarian Cancer Therapy
    Gong, Han
    Nie, Dan
    Li, Zhengyu
    CURRENT CANCER DRUG TARGETS, 2020, 20 (11) : 853 - 867
12345